RICERCA ITALIANA     

FIRB simili:

• 1 - Aspetti di base e funzionali di materiali polimerici ibridi inorganico-organici nanostrutturati
• 2 - NANOTECNOLOGIE E NANOSCIENZE ORGANICHE
• 3 - Microsistemi a Base di Polimeri (MICROPOLYS)
• 4 - Nuovi materiali e film polimerici nanostrutturati a ridotto impatto ambientale, con proprieta' di risposta verso agenti chimici e fisici, per il packaging flessibile. Studio di: fenomenologia microscopica, modelli e simulazioni, verifiche sperimentali e processi di polimerizzazione e miscelazione(NANOPACK).
• 5 - Studio di microsistemi multifunzionali per determinazioni chimiche e biochimiche in matrici biologiche complesse
• 6 - SINTESI DI NUOVI MATERIALI ORGANICI ED ARCHITETTURE SUPRAMOLECOLARI PER SISTEMI OPTOELETTRONICI E FOTONICI AD ELEVATA EFFICIENZA
• 7 - Sviluppo di microsistemi multisensoriali per applicazioni ambientali e agroalimentari
• 8 - Tecnologie per la manipolazione su scala nanometrica dei materiali e loro applicazione biomedica
• 9 - Sviluppo di microsistemi multifunzionali per analisi in diagnostica clinica e nel settore alimentare
• 10 - Composti molecolari e materiali ibridi nanostrutturati con proprietà ottiche risonanti e non risonanti per dispositivi fotonici.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Ingegneria industriale e dell'informazione
  • SCIENZA E TECNOLOGIA DEI MATERIALI

Classificazione brevettuale

• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agent employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toilet purposes A61K; preparation of ozone C01B13/10)

Classificazione geografica

• Regione: Toscana

Bibliografia

1. Edelman ER, Rogers C. Pathobiologic responses to stenting. Am J Cardiol 1998; 81(7A): 4E.
2. Schwartz R. Pathophysiology of restenosis: interaction of thrombosis, hyperplasia and/or remodelling. Am J Cardiol 1998; 81(7A): 14E.
3. Chakhtoura EY, et al. In-stent restenosis after carotid angioplasty-stenting: incidence and management. J Vasc Surg 2001; 33(2): 220.
4. de La Fuente LM, et al. Initial results of the Quanam drug eluting stent (QuaDS-QP-2) registry (BARDDS) in human subjects. Catheter Cardiovasc Interv 2001; 53(4): 480.
5. Sousa JE, et al. Lack of neointimal proliferation after implantation of Sirolimus-coated stents in human coronary arteries. Circulation 2001; 103: 192.
6. Bauernschmitt R, et al. Operation for infective endocarditis: results after implantation of mechanical valves. Ann Thorac Surg 1998; 65(2): 359.
7. Delay D, et al. Immediate and long-term results of valve replacement for native and prosthetic valve endocarditis. Ann Thorac Surg 2000; 70(4): 1219.
8. Mansur AJ, et al. Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J 2001; 141(1): 6.
9. Bertrand S, et al. Preliminary experience with Silzone-coated St. Jude medical valves in acute infective endocarditis. J Heart Valve Dis 2000; 9(1): 131.
10. van Beusekom HMM, van der Giessen WJ, van Ingren Schenau D, Slager CJ. Synthetic polymers as an alternative to metal in stents? In vivo and mechanical behavior of polyethylene-terephthalate. Circulation 1992; 86: 731.
11. van der Giessen WJ, Slager CJ, van Beusekom HMM et al. Mechanical features and in vivo behavior of a polymer stent. J. Am Coll. Cardiol 1992; 19: 49.
12. Murphy JG, Schwartz RS, Edwards WD, Camrud AR, Vlietstra RE, Holmes D. Percutaneous polymeric stents in porcine coronary arteries: initial experience with polyethylene terephthalate stents. Circulation 1992; 86: 1596.
13. Holmes DR, Camrud AR, Jorgenson MA, Edwards WD, SchwartzRS. Polymeric stenting in the porcine coronary artery model: differential outcome of exogenus fibrin sleeves versus polyurethane-coated stents. J. Am Coll Cardiol 1994; 24: 525.
14. De Scheerder IK, Wilczek K, Verbeken E et al. Amphiphilic polyurethane coating of intracoronary stents decreases mortality due to subacute thrombosis in porcine coronary model. J. Am Coll Cardiol 1994; 23: 186A.
15. Chiellini E, Solaro R, Multifunctional bioerodible/biodegradable polymeric materials. Macromol Symp.,1995; 98: 803.
16. Agrawal CM, Haas KF, Leopold DA, Clark HG. Evaluation of poly-L-lactic acid as a material for intravascular polymeric stent. Biomaterials 1992; 13: 176.
17. Lincoff AM, Furst JG, Ellis SG, Topol EJ. Sustained local drug delivery by a novel intravascular eluting stent to prevent restenosis in the porcine coronary artery. I Am Coll Cardiol 1994; 23: 18A
18. Giusti P, Lazzeri L, Barbani N, Lelli L, De Petris S, Cascone M.G. Blends of natural and synthetic polymers: a new route to novel biomaterials. Makromol. Chem. Macromol Symp. 1994 ; 78: 285.
19. Giusti P, Lazzeri L, De Petris S, Palla M, Cascone MG. Collagen-based new bioartificial polymeric materials. Biomaterials 1994; 15: 1229.
20. Giusti P, Lazzeri L, Cascone MG, Seggiani M. Blends of synthetic and natural polymers as special performance materials. Makromol. Chem., Macromol. Symp.1995; 100: 81.
21. Giusti P, Lazzeri L, Cascone MG Barbani N, Cristallini C. Bioartificial polymeric materials: natural and synthetic world joining in biomaterials research in Polymers and Other Advanced Materials: Emerging Technologies and Business Opportunities, Edited by P.N. Prasad et. al, Plenum Press, New York, 1995, pp. 563-569
22. Giusti P, Lazzeri L, Cascone MG. Bioartificial Polymeric Materials, in The Polymeric Materials Encyclopedia, CRC Press, Boca Raton, 1996 pp. 538-549.
23. Couvrer PC, Dubernet C, Puisieux F. Eur.J.Pharm. Biopharm.1995 ; 41 : 2.
24. Quintanar-Guerrero D, Alleman E, Fessi H, Doelker E. Drug Dev. Ind. Pharm.1998; 24: 1113.
25. Cascone MG, Zhu Z, Borselli F, Lazzeri L. Poly(vinyl alcohol) hydrogels as hydrophilic matrices for the release of lipophilic drugs loaded in PLGA nanoparticles. J. Mat. Sci.: Materials in Medicine 2001 (in stampa).
26. Cascone MG, Zhu Z, Maron Pot P, Lazzeri L. Release of dexametasone from PLGA nanoparticles entrapped into dextran/poly(vinyl alcohol) hydrogels. J. Mat. Sci.: Materials in Medicine 2001 (in stampa).
27. Wulff G, Angew. Chem. Int. Ed. Engl. 1995; 34: 1812.
28. Shea K.J. & Dougherty T.K. J. Am. Chem. Soc.1986; 108: 1091.
29. Andersson L.I., Nicholls I.A., Mosbach. Advances in Molecular and Cells Biology 1996; 15B: 651.

Parole Chiave

Dispositivi endovascolari; Rilascio di farmaci; Biomateriali; Polimeri biodegradabili; "Imprinting" molecolare; Test in-vitro ed ex-vivo